Evidence map›Paper›PMID 40830323›Full record

ArticleCurrent oncology reports2025

Multimodal Imaging to Improve Patient Selection and Optimize Treatment Planning and Delivery for Patients Undergoing Reirradiation: A Scoping Review.

Arnaud Beddok, Laura Rozenblum, Valentin Calugaru, Loic Feuvret, Laurence Champion, Catherine Ala Eddine, Gilles Crehange, Georges El Fakhri, Irène Buvat

Abstract readScoping Review
PubMed Publisher
In one paragraph

Article in Current oncology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Arnaud BeddokDepartment of Radiation Oncology, Institut Godinot, Reims, France. arnaud.beddok.mdphd@gmail.com.ORCID http://orcid.org/0000-0002-5512-4161
Laura RozenblumYale Biomedical Imaging Institute, Yale School of Medicine, New Haven, Connecticut, USA.
Valentin CalugaruDepartment of Radiation Oncology, Institut Curie, Paris, 75005, France.
Loic FeuvretDepartment of Radiation Oncology, East Group Hospital, Hospices Civils de Lyon, Lyon, 69000, France.
Laurence ChampionDepartment of Nuclear Medicine, Institut Curie, Saint-Cloud, 92210, France.
Catherine Ala EddineDepartment of Radiology, Institut Curie, Paris, 75005, France.
Gilles CrehangeDepartment of Radiation Oncology, Institut Curie, Paris, 75005, France.
Georges El FakhriYale Biomedical Imaging Institute, Yale School of Medicine, New Haven, Connecticut, USA.
Irène BuvatLaboratoire d'Imagerie Translationnelle en Oncologie, Inserm U1288, Institut Curie, PSL University, Paris Saclay University, Orsay, 91400, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of reviewAdvances in radiation therapy techniques that allow for better normal tissue sparing have made reirradiation (reRT) a more viable option for managing locoregional recurrences in various cancers. However, severe toxicity and a high risk of second recurrence persist, emphasizing the need for improved patient selection and treatment planning. This scoping review, registered in the PROSPERO database (CRD42023387364), followed PRISMA guidelines. A thorough search was conducted from 2012 to December 2023 in MEDLINE (via PubMed) and BioMed Central databases, focusing on studies that reported the value of multimodal imaging in enhancing patient selection and optimizing reRT planning. Inclusion criteria targeted studies involving MRI and PET imaging, with exclusions based on relevance, language, and quality. RECENT

findingsOf 363 records identified, 29 studies met inclusion criteria. Most focused on high-grade glioma (HGG, 48%), head and neck cancer (HNC, 31%), and pelvic cancer (21%). In HGG,

Indexed as

Multimodal ImagingNeoplasm Recurrence, LocalNeoplasmsPatient SelectionRadiotherapy Planning, Computer-AssistedRe-IrradiationHumansMagnetic Resonance ImagingPositron-Emission TomographyDiagnostic imagingImage processing, Computer-AssistedMagnetic resonance imagingNeoplasm recurrence, localPositron emission tomographyReirradiation

Identifiers

PMID40830323

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.